Graf Akcie GWPH (GW Pharmaceuticals). Diskuze k akciím GWPH. Aktuální informace GWPH.

Základní informace o společnosti GW Pharmaceuticals (Akcie GWPH)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 6.81B
Hodnota podniku (EV) N/A
Tržby 559.038M
EBITDA -51.65
Zisk -69.84
Růst v tržbách Q/Q 26.39 %
Růst v tržbách Y/Y 42.35 %
P/E (Cena vůči ziskům) 0.00
Forward P/E N/A
EV/Sales 11.53
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 12.19
P/FCF N/A
Price/Book 9.19
Účetní hodnota na akcii 0.01
Hotovost na akcii 0.01
FCF vůči ceně -0.58 %
Počet zaměstnanců 0
Tržba na zaměstnance N/A
Profit margin -11.03 %
Operating margin -11.73 %
Gross margin 92.88 %
EBIT margin -12.42 %
EBITDA margin -9.24 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -79.17 %
EPS - Očekávaný růst příští rok 4.17 %
Return on assets -7.64 %
Return on equity -9.54 %
ROIC -5.92 %
ROCE -8.97 %
Dluhy/Equity 0.27
Čistý dluh/EBITDA 34.83
Current ratio 4.49
Quick Ratio 3.63
Volatilita 1374.09
Beta 0.00
RSI 1.43
Cílová cena analytiků 184
Známka akcie (dle analytiků) 1.29
Insider ownership 0.20 %
Institutional ownership 80.35 %
Počet akcií 31.534M
Procento shortovaných akcií 0.00 %
Short ratio 1.15 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2013
Země United Kingdom

Finanční výsledky akcie GWPH

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$311.332-$12.737$8.629$14.694$43.744
Cost Of Goods Sold$27.199-$5.986$4.521$3.873$4.013
Gross Profit$284.133-$6.751$4.108$10.821$39.731
Research And Development Expenses$142.678-$153.736$112.249$142.187$117.69
SG&A Expenses$259.88-$141.818$58.02$28.403$19.265
Other Operating Income Or Expenses----$36.397$9.506
Operating Expenses$429.757-$301.54$174.79$138.065$131.461
Operating Income$-118.425-$-288.803$-166.161$-123.372$-87.718
Total Non-Operating Income/Expense$109.222-$-2.567$-5.33$0.62$0.259
Pre-Tax Income$-9.203-$-291.37$-171.491$-122.752$-87.459
Income Taxes$-0.184-$3.797$-1.032$-32.073$-19.156
Income After Taxes$-9.019-$-295.167$-170.459$-90.679$-68.303
Other Income------
Income From Continuous Operations$-9.019-$-295.167$-170.459$-90.679$-68.303
Income From Discontinued Operations------
Net Income$-9.019-$-295.167$-170.459$-90.679$-68.303
EBITDA$-109.185-$-279.513$-159.107$-118.148$-84.189
EBIT$-118.425-$-288.803$-166.161$-123.372$-87.718
Basic Shares Outstanding31-28252321
Shares Outstanding31-28252321
Basic EPS$-0.24-$-10.56$-6.72$-4.02$-3.33
EPS - Earnings Per Share$-0.24-$-10.56$-6.72$-4.02$-3.33
# 2020 2019 2018 2017 2016 2015
Current Ratio5.9513-6.65968.118211.57429.1883
Long-term Debt / Capital0.0076-0.0140.01640.01230.0062
Debt/Equity Ratio0.0077-0.01420.01670.0130.0067
Gross Margin91.2637-53.003147.606973.640390.8269
Operating Margin-38.0382--2267.433-1925.611-839.6218-200.5255
EBIT Margin-38.0382--2267.433-1925.611-839.6218-200.5255
EBITDA Margin-35.0703--2194.496-1843.864-804.0717-192.4597
Pre-Tax Profit Margin-2.956--2287.587-1987.38-835.4047-199.9334
Net Profit Margin-2.8969--2317.398-1975.42-617.1304-156.1423
Asset Turnover0.3529-0.0260.01950.02280.0985
Inventory Turnover Ratio0.318-0.3140.79750.64010.5505
Receiveable Turnover6.3689-6.00246.31240.39861.8396
Days Sales In Receivables57.3095-60.809557.823915.7024198.4096
ROE - Return On Equity-1.2422--71.0973-44.7607-15.9746-18.169
Return On Tangible Equity-1.2543--72.3094-45.5939-16.2121-18.5822
ROA - Return On Assets-1.0223--60.1725-38.4851-14.0468-15.3799
ROI - Return On Investment-1.2328--70.0989-44.0263-15.7782-18.0556
Book Value Per Share23.4795-14.64215.010822.54917.2722
Operating Cash Flow Per Share-3.98748.3322-2.4868-0.4975-1.879-2.9203
Free Cash Flow Per Share-1.92929.4406-2.8385-0.7056-1.0904-3.7339